JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flanagan, T. L.
Right arrow Articles by Heming, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flanagan, T. L.
Right arrow Articles by Heming, A. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 103, Issue 4, 215-221, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


TOXICITY STUDIES ON AMBERLITE XE-96, A CARBOXYLIC TYPE CATION EXCHANGE RESIN

Thomas L. Flanagan 1, Mary F. Sax 1, and Arthur E. Heming 1

1 Research Division, Smith, Kline & French Laboratories, Philadelphia, Penna.

1. Subacute and chronic toxicity studies in dogs and rats on feeding the purified ammonium salt of a carboxylic exchange resin, Amberlite XE-96 (SKF No. 648), in doses of 3-5 gm./kgm. daily from one week to six months, gave no evidence of changes due to administration of this cation exchanger.

2. Three successive generations of rats were fed SKF No. 648 at a level of 10 per cent of their food intake for periods of 500, 300, and 225 days, respectively. This uninterrupted administration of a carboxylic cation exchange resin did not produce any untoward effects in the animals of each generation, as evidenced by growth studies, hematological examination, reproduction record, tissue electrolyte content, endocrine gland weights, and histopathological examination of the principal organ systems, and is evidence, therefore, that this resin does not interfere with the absorption and utilization of vitamins, amino acids, and other essential nutrients.

3. Administration of a mixture of potassium and ammonium salts of this carboxylic resin, in the form of Resodec, to dogs for 170 days at a daily dose of 30 gm. produced no deleterious response.

4. The data obtained in these experiments provide sufficient evidence of safety, on both short and long-term administration, to justify the clinical evaluation of this resin preparation as an agent for producing sodium restriction in edema due to salt retention.

Submitted on June 28, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.